Professional Summary
Professional Overview
Brian Harraka is an accomplished finance executive with over 20 years of experience in the pharmaceutical and consumer goods industries. As the VP, Deputy Chief Financial Officer at Eisai US, he plays a pivotal role in overseeing the company's financial operations and strategic decision-making.
Experience Summary
Current Role
In his current role as VP, Deputy Chief Financial Officer at Eisai US, Brian is responsible for leading the company's financial planning, analysis, and reporting processes. He oversees a team of finance professionals and works closely with the Chief Financial Officer to drive financial strategies that support the organization's growth objectives. Under his leadership, Eisai US has achieved consistent year-over-year improvements in financial performance and operational efficiency.
Career Progression
Prior to his current role, Brian served as the VP, Deputy Chief Financial Officer and Corporate Controller at Eisai US, where he was instrumental in streamlining the company's financial systems and processes. Before joining Eisai, he held various finance leadership positions at Novartis, including Executive Director - Accounting, Director – Head Business Unit Finance and Cost Operations, and Director – Revenue Accounting. His early career experience includes roles in financial planning and reporting at Reckitt Benckiser and as a Senior Associate in Assurance at KPMG Peat Marwick.
Academic Background
Brian holds a Bachelor's degree in Accounting from the University of Delaware. He is a Certified Public Accountant (CPA) and has been recognized for his contributions to the finance and accounting profession.
Areas of Expertise
- Financial planning and analysis
- Operational and cost efficiency optimization
- Financial systems implementation and integration
- Financial reporting and compliance
- Strategic financial decision-making
- Team leadership and talent development
Professional Impact
During his tenure at Eisai US, Brian has played a crucial role in driving the company's financial performance and aligning its financial strategies with its overall business objectives. He has spearheaded the implementation of advanced financial reporting and forecasting systems, resulting in improved data-driven decision-making and enhanced organizational agility. Additionally, Brian's expertise in optimizing operational costs has contributed to Eisai US's ability to maintain a competitive edge in the pharmaceutical market.
Conclusion
With his extensive experience, strategic mindset, and strong leadership skills, Brian Harraka is a valuable asset to Eisai US. As the VP, Deputy Chief Financial Officer, he continues to drive financial excellence and contribute to the company's long-term success in the dynamic pharmaceutical industry.
